Breast cancer research and treatmentHumansMesothelinTriple Negative Breast NeoplasmsFemaleTumor Microenvironment
Mesothelin-expressing triple-negative breast cancer: a highly invasive and immunosuppressive subtype.
Zuxuan Zhao, Huizi Lei, Bingzhi Wang, Lei Guo, Lina Gao, Bingning Wang, Shan Zheng, Jianming Ying
Published: 202510.1007/s10549-025-07860-x
Abstract
INTRODUCTION: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with limited therapeutic options. Mesothelin (MSLN), a tumor-associated antigen with potential targeted drugs, has been reported to be positive in some…
Preview only. Read the full abstract at the source